Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update.
1Multiple Sclerosis Clinic,St. Michael's Hospital,University of Toronto,Toronto,Ontario,Canada.
Paul W
PW
O'Connor
2London Health Sciences Centre,Western University,London,Ontario,Canada.
Marcelo
M
Kremenchutzky
D000818:Animals; D002986:Clinical Trials as Topic; D017831:Diagnosis, Dual (Psychiatry); D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000175:diagnosis* / Q000188:drug therapy*; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D000069442:Natalizumab / Q000627:therapeutic use*; D016896:Treatment Outcome
D000069442:Natalizumab
Clinical neurosciences; Multiple sclerosis